1. AB0213 THE USE OF MUSCULOSKELETAL ULTRASOUND AND PATIENT REPORTED OUTCOMES TO IDENTIFY THE FACTOR TO GIVE RESIDUAL SYMPTOMS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN SDAI-REMISSION OR LOW DISEASE ACTIVITY. (2nd June 2020) Authors: Nawata, M.; Funada, M.; Fujita, Y.; Nagayasu, A.; Someya, K.; Kazuyoshi, S.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0102 SERUM TNFΑ LEVELS AT 24 HOURS AFTER FIRST ADMINISTRATION OF CERTOLIZUMAB PEGOL PREDICT EFFECTIVENESS AT WEEK 12 IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM TSUBAME STUDY (UMIN ID:0002381). (2nd June 2020) Authors: Miyazaki, Y.; Nakano, K.; Nakayamada, S.; Kubo, S.; Iwata, S.; Hanami, K.; Fukuyo, S.; Miyagawa, I.; Yamaguchi, A.; Kawabe, A.; Kazuyoshi, S.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗